ALK F1174V
|
NSCLC
|
ALK F1174V
|
NSCLC
|
ensartinib Sensitive: C3 – Early Trials
|
ensartinib Sensitive: C3 – Early Trials
|
ALK F1174V
|
NSCLC
|
ALK F1174V
|
NSCLC
|
alectinib Sensitive: C3 – Early Trials
|
alectinib Sensitive: C3 – Early Trials
|
ALK F1174V
|
NSCLC
|
ALK F1174V
|
NSCLC
|
brigatinib Resistant: C3 – Early Trials
|
brigatinib Resistant: C3 – Early Trials
|